Vericel Corp. (VCEL)
36.01
-0.72
(-1.96%)
USD |
NASDAQ |
Dec 31, 16:00
36.00
0.00 (0.00%)
After-Hours: 20:00
Vericel Market Cap: 1.821B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ADMA Biologics, Inc. | 4.341B |
| Vanda Pharmaceuticals, Inc. | 521.23M |
| Marker Therapeutics, Inc. | 24.84M |
| Veracyte, Inc. | 3.328B |
| Aldeyra Therapeutics, Inc. | 311.64M |
Market Cap Related Metrics
| PE Ratio | 149.54 |
| PS Ratio | 7.112 |
| PEG Ratio | 0.5231 |
| Price to Book Value | 5.658 |
| Price to Free Cash Flow | 90.30 |
| Price | 36.01 |
| Earnings Yield | 0.67% |
| PEGY Ratio | 0.5231 |
| Operating PE Ratio | 258.87 |
| Normalized PE Ratio | 149.48 |